🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this 6-month randomized multi-regional double-blind parallel gro...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-10-25
Trial ID
NCT05586958
Treatments Being Tested
This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interac...
Status
Completed
Location
PPD
Start Date
2020-01-22
Trial ID
NCT04139824
Treatments Being Tested
The aim of this 12-week randomized multicenter double-blind parallel group ...
Status
Completed
Location
Synexus Clinical Research
Start Date
2019-12-02
Trial ID
NCT03934099
Treatments Being Tested
A phase 1, open-label, drug-drug interaction study to evaluate the effect o...
Status
Completed
Location
PPD - Austin Research Unit
Start Date
2023-10-31
Trial ID
NCT06189404
Treatments Being Tested
IBI128 (Tigulixostat) is a novel non-purine selective inhibitor of xanthine...
Status
Completed
Location
Shanghai Fudan University HuaShan Hospital
Start Date
2024-07-10
Trial ID
NCT06501534
Treatments Being Tested
This is an open-label, randomized, crossover, single dose study. Two single...
Status
Completed
Location
PPD
Start Date
2021-07-31
Trial ID
NCT04886050
Treatments Being Tested
This is a Phase 1, single-center, randomized, partially double-blind, place...
Status
Completed
Location
PPD
Start Date
2021-09-23
Trial ID
NCT04966325
Treatments Being Tested
The aim of this 12-month randomized multi-regional double-blind parallel gr...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-03-30
Trial ID
NCT05586971
Treatments Being Tested
This is a Phase 1, open-label, parallel-group, multiple-dose study designed...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2019-11-19
Trial ID
NCT04066712
Treatments Being Tested
This is a Phase 1, open-label, single-dose, mass balance study designed to ...
Status
Completed
Location
PPD
Start Date
2020-02-26
Trial ID
NCT04070846
Treatments Being Tested